You searched for viral vector - Page 30 of 53

More News! 18 Nov 2017

Bacterial Art Starts a Debate on Money and International Borders

…visas or passports for microbes that hitch rides from hands, noses, and genitalia.” The artist compares how bacteria use money as vectors to colonize new places to how Europeans colonized…

November 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

hookipa cancer vaccine hiv cytomegalovirus

News and Trends 28 Feb 2019

Austrian Biotech Raises €33.2M to Fund Cancer Vaccines

…the US company Gilead. Currently at the preclinical stage, Hookipa recently achieved its first milestone stage of the collaboration, developing 14 viral vectors that could become promising HIV vaccines in…

February 28, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

…company developing gene therapies for sensorineural hearing loss, a condition with no approved genetic treatments yet. Akouos built its pipeline on a proprietary platform that uses adeno-associated viral (AAV) vectors,…

July 4, 2025 - 15 minutesmins - By Jules Adam

News and Trends 12 Jan 2023

Team wins $149M contract for National Institute of Neurological Disorders and Stroke

…energy and environmental industries. About Andelyn Biosciences, Inc. Andelyn is a biopharmaceutical CDMO in the greater Columbus, Ohio, area. Its capabilities span viral vector process and analytical development, small to…

January 12, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 6 Jun 2025

Beyond CRISPR: What CAST could bring to genome editing

…delivery systems like lipid nanoparticles or viral vectors. Recent studies have demonstrated the potential of Type V-K CASTs in human cells, showing successful integration of therapeutic genes at specific genomic…

June 6, 2025 - 7 minutesmins - By Jules Adam

News and Trends 29 Nov 2022

Touchlight receives new grant to further develop doggybone DNA vaccine platform

…DNA is already widely utilized across the genetic medicine market, in areas such as critical starting material for viral vector and mRNA vaccine production, genome editing and DNA vaccine applications….

November 29, 2022 - 2 minutesmins - By Liza Laws

News and Trends 12 Oct 2021

The Top European Biotech Investment Rounds in September

…the Swiss firm Anjarium Biosciences, which attracted €52.1M in biotech investments to package and deliver gene therapies to the patient’s cells via next-generation non-viral vectors. Another notable Series A round…

October 12, 2021 - 4 minutesmins - By Jonathan Smith

gene therapy blood disorder hemophilia b

News and Trends 27 Nov 2020

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

…were reported and the need for standard FIX replacement therapy went down by 96% compared to before the injection. uniQure’s gene therapy is introduced into the liver by a viral…

November 27, 2020 - 5 minutesmins - By Victor Kotsev

biogen nightstar therapeutics gene therapy ophthalmology

News and Trends 4 Mar 2019

Biogen Acquires UK Biotech Developing Gene Therapy for Blindness

…progressive blindness is to inject the retina with a viral vector carrying a healthy copy of the mutated gene responsible for the condition. As part of the deal, Biogen also…

March 4, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 5 Jul 2023

Six biotech companies leading the way in Hong Kong

…Hong Kong, Pacific GeneTech specializes in vaccine development. Its Aegis Vaccine platform employs recombinant technology to incorporate bacterial, viral or protozoan genes into microbial vectors. The vector expresses these genes…

July 5, 2023 - 7 minutesmins - By Roohi Mariam Peter

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

…in clinical development and stock price drops. Nonetheless, knowledge of gene therapy and safe use of its most common delivery method — viral vectors — is growing. “Everything is in…

January 21, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 1 Dec 2016

UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa

…by Sanofi Pasteur and consists of a viral vector containing genetically engineered versions of 3 HIV genes. The second is a protein vaccine supplied by GSK, which should create an…

December 1, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Bacterial Art Starts a Debate on Money and International Borders

Austrian Biotech Raises €33.2M to Fund Cancer Vaccines

14 biotech companies to know in the Boston area in 2025

Team wins $149M contract for National Institute of Neurological Disorders and Stroke

Beyond CRISPR: What CAST could bring to genome editing

Touchlight receives new grant to further develop doggybone DNA vaccine platform

The Top European Biotech Investment Rounds in September

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

Biogen Acquires UK Biotech Developing Gene Therapy for Blindness

Six biotech companies leading the way in Hong Kong

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!